Armen Shanafelt - Director at Spyre Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
SYRE on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Armen Shanafelt since 13 Jan 2025

Holdings reported by Armen Shanafelt for Spyre Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 150,000 $84,120 $0.5608 13 Dec 2021 Direct
Director Stock Option (right to buy) 43,000 07 Jun 2022 Direct Common Stock

Transactions reported by Armen Shanafelt for Spyre Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.